PRIORIX
LIVE

Serial Number

97254008

Owner

GlaxoSmithKline Biologicals SA

Attorney

Christopher M. Hanes

Filing Date

Feb 4, 2022

Add to watchlist:

No watchlists yet
View on USPTO

PRIORIX Trademark

Serial Number: 97254008 • Registration: 7431303

PRIORIX is a trademark filed by GlaxoSmithKline Biologicals SA on February 4, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

GlaxoSmithKline Biologicals SA (140 trademarks)

Rue de l'Institut 89
B-1330 Rixensart , BE

Entity Type: 99

Trademark Details

Filing Date

February 4, 2022

Registration Date

July 2, 2024

Published for Opposition

April 16, 2024

Goods & Services

Vaccines

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 2, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 2, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 16, 2024 NPUB
PUBLISHED FOR OPPOSITION
Apr 16, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 27, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 9, 2024 CNSA
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Feb 26, 2024 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Aug 24, 2023 RCSC
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Aug 12, 2023 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jan 28, 2023 RCSC
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 3, 2022 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Aug 3, 2022 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 3, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 3, 2022 REAP
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jul 11, 2022 GNS3
LETTER OF SUSPENSION E-MAILED
Jul 11, 2022 GNSL
SUSPENSION LETTER WRITTEN
Jul 11, 2022 CNSL
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 8, 2022 GNRN
NON-FINAL ACTION E-MAILED
Jul 8, 2022 GNRT
NON-FINAL ACTION WRITTEN
Jul 8, 2022 CNRT
ASSIGNED TO EXAMINER
Jun 29, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 9, 2022 NWOS
NEW APPLICATION ENTERED
Feb 8, 2022 NWAP